We have explored the hypothesis that contractile agonists are important regulators of smooth muscle cell growth by examining the effects of one potent contractile agonist, angiotensin II (All), on both cell proliferation and cellular hypertrophy. All neither stimulated proliferation of cells made quiescent in a defined serum-free media nor augmented cell proliferation induced by serum or platelet-derived growth factor. However, All did induce cellular hypertrophy of postconfluent quiescent cultures following 4 days of treatment, increasing smooth muscle cell protein content by 20% as compared with vehicle-treated controls. All-induced hypertrophy was maximal at 1 |xM, had an ED n of 5 nM, and was blocked by the specific All receptor antagonist Sar^Ile' All. The cellular hypertrophy was due to an increase in protein synthesis, which was elevated within 6-9 hours following All treatment, while no changes in protein degradation were apparent. ATI was even more effective in inducing hypertrophy of subconfluent cultures, causing a 38% increase in protein content after 4 days of treatment (1 |AM) and showing a maximal response at concentrations as low as 0.1 nM.
T here is considerable interest in the cellular mechanisms involved in the control of vascular smooth muscle growth and its role in the etiology of hypertension and atherosclerosis. It has been demonstrated that aortic smooth muscle cells (SMC) are capable of two distinct cellular growth responses in vivo, depending on the mode of growth stimulation. 1 " 7 Coarctation models and experimental injury models of atherosclerosis are characterized by extensive proliferation and intimal migration of aortic SMC.'" 3 In contrast, in Goldblatt and spontaneously hypertensive rats, the increase in aortic smooth muscle mass can be accounted for primarily by enlargement of existing cells, or cellular hypertrophy, rather than cellular proliferation. 4 " 7 Interestingly, SMC hypertrophy is often accompanied by increases in ploidy. However, SMC hypertrophy is not dependent on development of poryploidy because diploid cells from hypertensive animals are also hypertrophied with respect to diploid cells from normotensive controls. 7 There is indirect evidence that SMC hypertrophy may represent a response to increased blood pressure. We consistently have observed a high degree of correlation between blood pressure and SMC hypertrophy and hyperploidy. 6 -9 Furthermore, pharmacolog-ical lowering of blood pressure can prevent development of SMC hypertrophy and hyperploidy and can reverse cellular hypertrophy that already has occurred in spontaneously hypertensive rats. 8 " 10 However, these data must be interpreted with caution because there is no direct evidence that these effects on growth are due to lowering of blood pressure as opposed to some other direct or indirect effect of the drugs on cellular DNA and protein synthesis. In fact, recent drug intervention studies in this and other laboratories have demonstrated dissociation of blood pressure changes and SMC hypertrophy and hyperploidy in spontaneously hypertensive rats treated with different antihypertensive drugs. 910 Results suggested that medial SMC hypertrophy was not simply a response to increased blood pressure and implicated a direct role of specific contractile agonists in control of SMC growth. For example, we observed that captopril, a converting enzyme inhibitor, was more effective than hydralazine or propranolol in preventing hypertrophy of aortic SMC in spontaneously hypertensive rats than was predicted based on the magnitude of the decrease in blood pressure, implicating a role for angiotensin (All). Similarly, Yamori and coworkers 10 have presented indirect evidence that catecholamines might be involved in regulation of SMC growth.
The hypothesis that contractile agonists might play some direct role in mediation of SMC growth is of interest because it may explain how an SMC might alter its mass in response to an induced change in its work load. It is worth noting that contractile agonists share many common intracellular signaling mechanisms with growth factors."" 24 However, very few studies have been done to explore the possible growth properties of contractile agonists in SMC, and no studies have specifically explored the potential role of contractile agonists in mediation of cellular hypertrophy. Thus, in the present studies, we have addressed the possible role of one contractile agonist, All, in regulation of SMC growth by studying the effect of All on both proliferation and hypertrophy in cultured rat aortic SMC.
Materials and Methods

Cell Culture
Rat thoracic aortic smooth muscle cells were isolated and cultured by the procedure described previously 25 with the following changes: 150-175-g rats were used instead of 200-225-g rats, and the following enzymes in Hanks' Balanced Salt solution were used for cell isolations: 1 mg/ml collagenase (type II, 158 M-/mg, Cooper Biomedical, Freehold, New Jersey), 0.25 mg/ ml elastase (type I, 3 p-/mg, Cooper Biomedical), 1 mg/ml soybean trypsin inhibitor (Cooper Biomedical).
Cells were harvested for passaging at confluency (approximate 5-day intervals) with trypsin-EDTA (0.05% trypsin, 0.02% EDTA, GIBCO, Grand Island, New York) solution and plated at 2-5 x 10 3 cells/cm 2 . Passaged cells were grown in a one-to-one mixture of Dulbecco's Modified Eagle Medium (GIBCO) and Ham's F12 medium (GIBCO), containing either 10% fetal bovine serum (FBS, Hyclone, Logan, Utah), L-glutamine (0.68 mM, Sigma Chemical, St. Louis, Missouri), penicillin (100 U/ml) and streptomycin (100 (xg/ml) (designated DF10) or insulin (5xlO~7 M, Sigma Chemical), transferrin (5 M-g/ml, Sigma Chemical), ascorbate (0.2 mM, Sigma Chemical), L-glutamine, and antibiotics (designated serum-free medium, SFM). This SFM has been shown to maintain SMC in a quiescent, noncatabolic state for extended periods of time 26 and to promote expression of smooth muscle specific contractile proteins. a -" Cell cultures were incubated at 37° C in a humidified atmosphere of 5% CO 2 -95% air with media changes every 2-3 days.
Growth Curves
Cultures were washed with a calcium-magnesium free phosphate-buffered saline (PBS) containing (mM) NaCl 137, N a^P O^. l , KC12.7, and KH 2 PO 4 1.5, pH 7.4 harvested with trypsin-EDTA, diluted with 0.85% NaCl (Columbia Diagnostics, Springfield, Virginia), and counted on a Particle Data Electrozone Celloscope (Elmhurst, Illinois) with orifice size of 95 |xm and sample volume of 500 p.1. Triplicate wells were counted for each group at every time point.
[ 3 H]Thymidine Autoradiography
Cultures were pulsed with [ 3 H]thymidine (1 jiCi/ml, 6.7 Ci/mmol, New England Nuclear, Boston, Massachusetts) in culture medium. Two hours later, cultures were washed twice with PBS and fixed in 2% glutaraldehyde for 5 minutes, dehydrated, and coated with Kodak NTB2 emulsion (Rochester, New York) (diluted 1:1 with distilled water). Dishes were exposed for 4 days at 4° C and then developed in D-19 (Eastman Kodak), fixed with Rapid-Fix (Eastman Kodak), and stained with hematoxylin. The percentage of cells synthesizing DNA was determined by counting the number of labeled cells (nuclei) in a random sample of at least 1,000 cells from each dish. Triplicate dishes were analyzed for each sample point.
Flow Microfluorimetric Analysis of Cellular DNA and Protein Content
Cultures were washed with PBS and harvested using either trypsin-EDTA or 1 mg/ml collagenase, 0.25 mg/ml elastase, and trypsin (0.25%, GIBCO) in Hanks' Balanced Salt solution. Samples were divided for protein and DNA analysis and then centrifuged (113g, 6 minutes). For the protein staining, cells were fixed in 75% methanol/25% PBS on ice for 30 minutes, centrifuged (113g, 6 minutes), stained with FITC (75 ng/ml fluorescein isothiocyanate, Sigma Chemical; 0.5 M NaHCOj, pH 8) on ice for 30 minutes, and then centrifuged (113g, 6 minutes) and resuspended in 0.85% NaCl. For measurement of DNA, cells were stained with either propidium iodide (Sigma Chemical) or Hoechst 33258 (Sigma Chemical). For propidium iodide staining, cells were resuspended in a propidium iodide staining solution (propidium iodide 50 ng/ml, NaCl 150 mM, Tris base 100 mM, CaCl 2 1 mM, MgSO 4 0.54 mM, MgCl 2 103 mM, bovine serum albumin [BSA, Fraction V, Sigma Chemical] 2 mg/ml, concentrated HC10.7% vol/vol, NP40 0.6% vol/vol), kept on ice 5 minutes, centrifuged (113g, 6 minutes), and resuspended in the propidium iodide staining solution. For the Hoechst staining, cells were fixed for 30 minutes on ice in 75% methanol/25% PBS, centrifuged (113g, 6 minutes), and resuspended in a Hoechst 33258 staining solution (Hoechst 33258 0.58 (xg/ml, NaCl 145 mM, Tris 100 mM). All samples for protein and DNA measurements were kept on ice until analyzed on a Coulter Epics V fluorescence activated cell sorter (Hialeah, Florida). Cell clumping was less than 1% based on analysis of peak versus integrated fluorescence.
Protein Synthesis
Cultures were treated with either All or vehicle (control) in SFM. Beginning at time of treatment and then every 3 hours, cultures were pulsed with ["SJmethionine (2.0 n,Ci/ml, 1,100 Ci/mmol, New England Nuclear). Cold L-methionine (1 mM, Sigma Chemical) was added to reduce possible pool effects on protein determination, as recommended by Rannels et al. 28 At the end of the 3-hour interval, the culture was washed with PBS, and the cells were enzymaticalry harvested into tubes containing 10 n-g BSA in solution. Trichloroacetic acid (TCA) was added to each tube for a final concentration of 10%, and samples were kept on ice for a minimum of 20 minutes. TCA-precipitable counts were collected on Whatman GF/F filters (Maidstone, England) and counted in 5 ml Scintiverse II (Fisher Scientific, Springfield, New Jersey) in a I.0E5-«I0E4-
Days following plating
Beckman LS8100 liquid scintillation counter (Irvine, California).
Protein Degradation
Protein degradation assays were performed as described by Libby and O'Brien. 29 Briefly, cells were loaded with [ 14 C]tyrosine (0.2 ^Ci/ml, 500mCi/mmol, New England Nuclear) in SFM for 3 days. Cultures were then washed and incubated twice for 1-hour intervals with SFM plus 5 mg/ml BSA to remove short-lived proteins. Dishes were then fed with SFM plus 1 mM tyrosine and either All, vehicle (control), or 10% FBS. At 12 hours, the medium was removed and replaced with fresh medium. At 24 hours, the medium was removed, and perchloric acid-insoluble material was collected from the dish. Medium removed at 12 and 24 hours was treated with perchloric acid (final concentration 0.2 M) and BSA (final concentration 2 mg/ml) and centrifuged in a table-top microfuge, and the supernatant was counted. Acid-insoluble material from each dish was collected in 1% sodium dodecyl sulfate in 5 mM NaOH after a 0.2 M perchloric acid treatment and two washes with Hanks' Balanced Salt solution.
The fraction of cell protein degraded during the time interval was calculated by dividing the counts obtained during a specific time interval by the total counts obtained by summing all time intervals plus the counts FIGURE 1. Influence of angiotensin 11 (All) on smooth muscle cell cultures fed either serum free medium (circles), 10% fetal bovine serum (squares), or serum free medium + partially purified platelet-derived growth factor (2.5 nglmL, triangles) and treated with either All (1 \xM, solid symbols) or vehicle (open symbols). Cell counts were performed at time zero and at 2-day intervals thereafter using an Electrozone Celloscope. Each sample was counted at least three times, and triplicate wells were evaluated for each group at each time point. Values are expressed as mean ± SEM, n = 3. All-treated groups were not significantly different from respective control (p > 0.05). Results similar to these were obtained in four independent experiments. obtained from the acid-insoluble material collected at the end of the experiment.
Statistics
All results were analyzed by either Student's t test or an analysis of variance combined with Newman-Keuls multiple range test for intergroup comparisons. Probabilities of 0.05 or less were interpreted as being statistically significant. Values reported in the text are mean ± SEM.
Results
Effects of Angiotensin II on Smooth Muscle Cell Proliferation
To determine whether All would induce proliferation of rat aortic SMC, cell counts were obtained from cultures that were maintained in SFM for 3 days to induce quiescence and were then treated with All (1 M) or vehicle in either 10% FBS, partially purified platelet-derived growth factor (PDGF, 2.5 ng/ml; a gift from R. Ross) in SFM, or SFM alone ( Figure 1 ). Results demonstrated that All was not mitogenic by itself nor did it augment the growth response to serum (p>0.05). The failure to see an enhanced growth response in the presence of serum was unlikely due to degradation of All because no response was seen with Sar 1 All, a more stable analogue of All (data not shown). In addition, All did not enhance the growth Likewise, flow microfluorimetric analysis of cell cycle of postconfluent cultures demonstrated that by far the majority of cells were in G o /G, with few cells in S + G 2 , and no differences were observed between the All-treated and control groups (Figure 2 ).
Effects of Angiotensin II on Cellular Protein Content
Although All was not mitogenic for rat aortic SMC, it did induce cellular hypertrophy (Figure 3 ). We chose to assess cellular hypertrophy, defined as an increase in mass or size of a cell, by flow microfluorimetric analysis of eel lular protein content because greater than 50% of the dry mass of the cell is made up of protein and nucleic acids and the remaining components of the cell are largely dependent on them." The mean protein content of All-treated cells (1 u,M All in SFM, 4 days) was increased by approximately 20% in postconfluent cultures as compared with the vehicle-treated control cultures (Figure 4 ). Cultures in 10% FBS treated with either All or Sar' All showed no increase in protein content as compared with the control cultures (data not shown). The All-induced increase in protein content in quiescent cultures (i.e., those maintained in SFM) was concentration-dependent with the maximal response seen at 1 u.M in postconfluent cultures ( Figure 5 ).
Receptor Dependence of the Angiotensin II Hypertrophic Response
Cultures were treated daily for 4 days with equimolar concentrations of All and either Sar 1 ,He 8 All (an All receptor antagonist) or Des-Phe 8 All (a biologically inactive All analogue). Cellular hypertrophy was then analyzed by flow microfluorimetric analysis of cellular protein content. Sar 1 ,He 8 All completely blocked the All-induced hypertrophy, while Des-Phe 8 All had no effect ( Figure 6 ). When used alone, neither analogue exerted any effect on protein content. While the observation that Allinduced hypertrophy in postconfluent cultures occurred over several log orders of concentration is of some concern, the fact that hypertrophy was blocked by the highly specific All antagonist, Sar 1 ,He 8 All, strongly indicates that the hypertrophic response is receptor mediated. Likewise, the observation that Des-Phe 8 All did not effect the All-induced hypertrophy indicates that the response to All did not involve some non-receptor-mediated effect of AIL It is likely that the gradual slope of the concentrationdependence curve in postconfluent cultures is due to degradation of All in these high cell density cultures and that the true concentration of AH is less than that calculated based on what was added.
Effects of Angiotensin II on Protein Synthesis and Degradation
The increase in protein content observed in Alltreated cultures could reflect either an increase in protein synthesis or a decrease in protein degradation Control All or some combination of the two. To test the first possibility, cultures of quiescent SMC were treated with All (1 u.M) or vehicle (control) in SFM, and relative rates of protein synthesis were determined at 3-hour intervals for a total of 75 hours following initiation of treatment. Results indicated that protein synthesis was significantly elevated in All-treated cells by 6-9 hours following initial treatment (Figure 7) and remained elevated for the 75-hour duration of the experiment. In contrast, All-treatment had no net effect on protein degradation rates (Figure 8 ). The Allinduced increase in [ 35 S]methionine incorporation into protein was blocked by Sar'Jle 8 All (data not shown). Additional studies were done in which cultures were pulsed with All for varying periods of time ranging from 5 minutes to 24 hours and protein synthesis assessed between 12 and 24 hours. Results demonstrated that a minimum 3-hour exposure to All was necessary to increase the rate of protein synthesis. In contrast to the effects of All, addition of 10% FBS to cells in SFM both increased protein synthesis and decreased the rate of protein degradation, although in this case, there was also a significant mitogenic response ( Figure 1 , Table 1 ).
Response of Subconfluent Cultures to Angiotensin II
To determine whether cell density or contact inhibition of growth might be an important component of All-induced SMC hypertrophy, whether All could induce cellular hypertrophy in subconfluent cells made quiescent by maintenance in SFM was explored. All (1 u,M) induced a 38% increase in cellular protein content in subconfluent cultures treated continuously with the peptide for 4 days (Figure 9 ). All was extremely potent in inducing hypertrophy under these conditions in that a maximum response was obtained at a concentration of 0.1 nM (data not shown).
An interesting observation in studies of subconfluent SMC was that a large increase in the fraction of cells in G 2 occurred in All-treated cultures as compared with control ( Figure 10 ), despite an extremely low fraction of cells in the S-phase based on either flow cytograms ( Figure 10) or [ 3 H]thymidine autoradiography ( Table  1 ). The mean fraction of cells in G 2 in the All-treated (1 ^M) and control cultures was 25.1 ± 0 . 6 % and 10 1-3 16 .7% ± 1 . 1 , respectively, following 4 days of treatment.
Discussion
In the present study, we have explored the hypothesis that contractile agonists are involved in the mediation of growth of cultured vascular SMC by examining the effects of one potent contractile agonist, All, on SMC hypertrophy and cell proliferation. Under the conditions examined, All neither was mitogenic nor potentiated the proliferative responses to FBS or PDGF. The failure of All to stimulate proliferation of rat aortic SMC in the present study contrasts with results of Campbell-Boswell and Robertson, 30 who found that All increased growth rates of subconfluent human aortic SMC in the presence of 10% FBS. The differences in the results of our study and that of Campbell-Boswell and Robertson may reflect either a species difference or differences in serum. The failure of All to enhance growth of rat aortic SMC in 10% FBS probably was not because the SMC were already maximally stimulated since All also did not augment the replication induced by submaximal doses of PDGF. Alternately, the differences may relate to differences in the differentiational status of the rat SMC used in the present study as compared with the human SMC used by Campbell-Boswell and Robertson. We have previously demonstrated that under the conditions used in these studies, our cells express high levels of smooth muscle-specific contractile proteins, 23 -27 while the explant-derived SMC used by Campbell-Boswell and Robertson were most likely highly modulated and expressed little, if any, of these differentiated proteins. 31 Although All was not mitogenic for rat aortic SMC in these studies, we found that it was extremely potent in inducing receptor-dependent hypertrophy of both subconfluent and postconfluent quiescent SMC. It is of interest that the degree of hypertrophy observed in these cultured SMC (i.e., 20% and 38% increases in protein content in postconfluent and subconfluent cells, respectively) is comparable to that observed in aortic SMC in vivo in the spontaneously hypertensive rat following development of chronic hypertension, where the protein content of diploid aortic SMC is increased between 20% and 50%. 6 An extremely interesting observation in subconfluent cells was that All induced a 50% increase in the fraction of cells in G 2 without a detectable increase in the fraction of cells in S-phase of the cell cycle. Whether this represents induction of true tetraploidy (i.e., doubling of chromosome number in quiescent cells) as has been shown to occur in vivo in conjunction with SMC hypertrophy 6 or whether it represents arrest of cells in the G 2 phase of the cell cycle will require extensive further investigation. Nevertheless, results indicate that the SMC hypertrophy induced in vitro resembles hypertrophy that occurs in vivo in many respects and that this model will be very useful in exploring the underlying mechanisms involved in SMC hypertrophy. Indeed, these studies lend support for a role of All in the in vivo hypertrophic response, as initially suggested by our drug intervention studies. 9 However, we caution that these studies provide no direct evidence as to the factors that mediate SMC hypertrophy in vivo in models such as the spontaneously hypertensive rat. The mechanism whereby All induces SMC hypertrophy is not known. All may increase protein synthesis by stimulation of ribosomal protein S6 phosphorylation, which is believed to play a role in control of protein synthesis. This could occur through AII- stimulated Na + -H + exchange, l6 -17 which has been implicated in control of S6 phosphorylation. 21 -32 Alternatively, All may have a direct effect on ribosomal genes. Robertson and Khairallah 33 have shown that All, or a rapidly formed degradation product, is found in the perinuclear space in coronary smooth muscles and cardiac myocytes within 45 seconds after injection of All into the vena cava. Also, Re et al 34 have shown that All binds with high affinity to nuclear membranes. Another possibility is that All could increase protein synthesis via increased intracellular Ca 2+ , which has been implicated in skeletal muscle hypertrophy. 35 One other possibility that must be considered is that the increased protein synthesis may be induced by mechanical forces, although it is unclear whether All causes active stress development in these cells and how this might result in increased protein synthesis. It is interesting to note that contractile agonists and growth factors have many properties in common. Both types of agents have been reported to mobilize intracellular calcium,' 1 " 14 increase inositol trisphosphate turnover, 1516 activate the sodium-proton antiport, 17 " 21 and have overlapping protein phosphorylation profiles. 22 Also, PDGF and other growth factors cause contraction of aortic rings. 23 -24 Thus, the response of a cell to a contractile agonist involves similar intracel-FIGURE 7. Influence of angiotensin II on protein synthesis rates. Cells were plated and grown to confluency in DF10 and then switched to serum free medium for 3 days to induce quiescence. At time zero, all cultures were refed with serum free medium and treated with either vehicle or AH (1 \iM lular signals as growth factors but does not stimulate cell division. In light of the current concept of cellular growth control as requiring multiple signals (or factors) in a finite temporal sequence (see reviews by Baserga 36 and Rozengurt 37 ), it is interesting to speculate that All might induce cellular hypertrophy and hyperploidy by acting as a partial growth factor, activating only a subset of the intracellular messengers necessary for complete cell replication. For example, All stimulation might increase cellular size and protein content as is known to occur during normal cell cycle progression 36 and, in very limited cases, DNA replication but not those signals requisite for cytokinesis. This hypothesis obviously remains to be tested but is consistent with the suggestion by Baserga 38 that there may be separate growth factors for cell hypertrophy versus DNA replication. We should note that the accumulation of significant numbers of cells with tetraploid DNA content could occur with very small increases in the fraction of cells undergoing DNA replication if it occurred over a relatively long time period. This might explain why we failed to see a statistically significant increase in the fraction of cells in S-phase using a 2-hour [ 3 H]thymidine pulse (see Table 1 ) but did see an increase in the fraction of cells with tetraploid DNA with chronic All treatment. One must also consider the alternative possibilities that the accumulation of cells with 4C DNA occurs as a result . Influence of angiotensin II (All) on subconfluent quiescent cultures of smooth muscle cells. Cells were plated in DF10 at 3X10 3 cells/cm 2 . Medium was changed to serum free medium 24-48 hours later. After 3-5 days, cultures were treated with All for 4 days. Protein content was determined as shown in Figure 3 . Results are mean ± SEM of three independent experiments. The All-treated group is significantly greater than control (p<0.05).
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of cell fusion 39 or by selective replication of a preexisting tetraploid population.
In summary, results of the present study demonstrate that All is a potent hypertrophic agent for cultured rat aortic SMC. Findings are consistent with the hypothesis that contractile agonists may modulate SMC hypertrophy and thereby provide a mechanism for SMC to regulate its mass in response to its work load. Further studies are required to determine the cellular mechanisms responsible for All-induced hypertrophy, whether the hypertrophy observed with All is also a property of other contractile agonists, and whether such mechanisms are important in mediation of smooth muscle hypertrophy in vivo. FIGURE 10 . Cell cycle histogram obtained from subconfluent cultures using Hoechst 33258 stain. Staining cultures were maintained in serum free medium for 3 days and then treated with either angiotensin II (1 \iM, ) or vehicle (control, ) for 4 days.
